The endocrine basis of benign breast disorders
暂无分享,去创建一个
[1] R. Millis,et al. Problems in Breast Pathology , 2006, Virchows Archiv.
[2] R. Hawkins,et al. Oestrone sulphate, adipose tissue, and breast cancer , 2005, Breast Cancer Research and Treatment.
[3] R. Santen,et al. Estrone sulfate: A potential source of estradiol in human breast cancer tissues , 2005, Breast Cancer Research and Treatment.
[4] O. Sartorius. The biochemistry of breast cyst fluids and duct secretions , 1995, Breast Cancer Research and Treatment.
[5] N. Whitworth. Lactation in humans , 1988, Psychoneuroendocrinology.
[6] L. Dogliotti,et al. Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study. , 1988, European journal of cancer & clinical oncology.
[7] R. Mansel,et al. ABERRATIONS OF NORMAL DEVELOPMENT AND INVOLUTION (ANDI): A NEW PERSPECTIVE ON PATHOGENESIS AND NOMENCLATURE OF BENIGN BREAST DISORDERS , 1987, The Lancet.
[8] D. Rose,et al. A comparison of serum and breast duct fluid‐immunoassayable prolactin and growth hormone with bioassayable lactogenic hormones in healthy women and patients with cystic breast disease , 1987, Cancer.
[9] J. Bonneterre,et al. Prognostic significance of prolactin receptors in human breast cancer. , 1987, Cancer research.
[10] M. Massobrio,et al. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. , 1987, European journal of cancer & clinical oncology.
[11] L. Murphy,et al. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. , 1987, Cancer research.
[12] R. Dickson,et al. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. , 1987, Endocrine reviews.
[13] J. Russo,et al. Development of the Human Mammary Gland , 1987 .
[14] L. Murphy,et al. Biological actions of prolactin in human breast cancer. , 1987, Recent progress in hormone research.
[15] L. Dogliotti,et al. Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. , 1986, European journal of cancer & clinical oncology.
[16] J. Deslypere,et al. Steroid dynamics in the normal and carcinomatous mammary gland. , 1986, Journal of steroid biochemistry.
[17] L. Dogliotti,et al. Prolactin Dynamics after Acute Stimulation with Thyrotropin‐Releasing Hormone and Domperidone in Women with Fibrocystic Disease of the Breast , 1986 .
[18] R. Santen,et al. Enzymatic Control of Estrogen Production in Human Breast Cancer: Relative Significance of Aromatase versus Sulfatase Pathways , 1986, Annals of the New York Academy of Sciences.
[19] A. V. Landeghem,et al. Uptake and Concentration of Steroid Hormones in Mammary Tissues , 1986, Annals of the New York Academy of Sciences.
[20] T. Oka,et al. 4 Paracrine regulation of mammary gland growth , 1986 .
[21] T. Oka,et al. Paracrine regulation of mammary gland growth. , 1986, Clinics in endocrinology and metabolism.
[22] P. Eskildsen,et al. Release of prolactin, thyrotropin, and growth hormone in women with cyclical mastalgia and fibrocystic disease of the breast , 1985, Cancer.
[23] M. Fleisher,et al. Plasma steroid-binding proteins in the cysts of gross cystic disease of the breast. , 1985, The Journal of clinical endocrinology and metabolism.
[24] K. Griffiths,et al. Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer. , 1985, European journal of cancer & clinical oncology.
[25] L. Dogliotti,et al. Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast. , 1985, Hormone research.
[26] P. Stell,et al. Serum progesterone concentration during the luteal phase in women with benign breast disease. , 1984, European journal of cancer & clinical oncology.
[27] L. Dogliotti,et al. Thyroid hormone levels in human breast cyst fluid. , 1984, Acta endocrinologica.
[28] M. Breckwoldt,et al. Serum Prolactin Levels in Patients With Fibrocystic Breast Disease , 1984, Obstetrics and gynecology.
[29] A. Herz,et al. Endocrine Actions of Opioids , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[30] G. Muccioli,et al. Presence and characterization of prolactin receptors in human benign breast tumours. , 1984, European journal of cancer & clinical oncology.
[31] R. Newcombe,et al. Prolactin response to thyrotropin‐releasing hormone stimulation and dopaminergic inhibition in benign breast disease , 1984, Cancer.
[32] A. D'ercole,et al. Insulin and insulin-like growth factors/somatomedins in fetal and neonatal development. , 1984, Clinics in endocrinology and metabolism.
[33] I. Cooke,et al. Luteal-phase insufficiency , 1984 .
[34] W. Miller,et al. The morphological basis of human breast cyst populations , 1983, The British journal of surgery.
[35] A. Forrest,et al. Classification of human breast cysts according to electrolyte and androgen conjugate composition. , 1983, Clinical oncology.
[36] R. Frairia,et al. Evidence for a transcortin-like component in human breast cyst fluid. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[37] R. Greenblatt,et al. Fibrocystic "disease" of the breast. , 1982, The New England journal of medicine.
[38] A. Pontiroli,et al. Effects of naloxone on prolactin, luteinizing hormone, and cortisol responses to surgical stress in humans. , 1982, The Journal of clinical endocrinology and metabolism.
[39] C. Bodian,et al. Breast Carcinoma: Risk and Detection , 1981 .
[40] M. Fleisher,et al. Steroid hormone accumulation in human breast cyst fluid. , 1981, Cancer research.
[41] R. Noble,et al. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. , 1980, The Journal of clinical endocrinology and metabolism.
[42] W. Miller,et al. Dehydroepiandrosterone sulphate in breast secretions. , 1980, Journal of steroid biochemistry.
[43] F. Halberg,et al. Circadian mesor-hyperprolactinemia in fibrocystic mastopathy. , 1979, The American journal of medicine.
[44] J. O'brien,et al. "EXHAUSTED" PLATELETS CONTINUE TO CIRCULATE , 1978, The Lancet.
[45] W. Malarkey,et al. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. , 1977, Cancer research.
[46] E. N. Cole,et al. Serum prolactin concentrations in benign breast disease throughout the menstrual cycle. , 1977, European journal of cancer.
[47] I. Mowszowicz,et al. Inadequate corpus luteal function in women with benign breast diseases. , 1977, The Journal of clinical endocrinology and metabolism.
[48] H. Nagasawa,et al. Prolactin and murine mammary tumorigenesis: a review. , 1977, Cancer research.
[49] F. Kuttenn,et al. Mastopathies bénignes: étude hormonale chez 125 malades. , 1977 .
[50] J. Meites,et al. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development. , 1976, Cancer research.
[51] R. Sellwood,et al. Sex hormones in breast disease , 1975, The British journal of surgery.
[52] D. Parker,et al. Sleep-related, nychthermeral and briefly episodic variation in human plasma prolactin concentrations. , 1973, The Journal of clinical endocrinology and metabolism.